» Articles » PMID: 35743362

Uterine Septum with or Without Hysteroscopic Metroplasty: Impact on Fertility and Obstetrical Outcomes-A Systematic Review and Meta-Analysis of Observational Research

Abstract

Objective: we performed a systematic review/meta-analysis to evaluate the impact of septate uterus and hysteroscopic metroplasty on pregnancy rate-(PR), live birth rate-(LBR), spontaneous abortion-(SA) and preterm labor (PL) in infertile/recurrent miscarriage-(RM) patients. Data sources: a literature search of relevant papers was conducted using electronic bibliographic databases (Medline, Scopus, Embase, Science direct). Study eligibility criteria: we included in this meta-analysis all types of observational studies that evaluated the clinical impact of the uterine septum and its resection (hysteroscopic metroplasty) on reproductive and obstetrics outcomes. The population included were patients with a diagnosis of infertility or recurrent pregnancy loss. Study appraisal and synthesis methods: outcomes were evaluated according to three subgroups: (i) Women with untreated uterine septum versus women without septum (controls); (ii) Women with treated uterine septum versus women with untreated septum (controls); (iii) Women before and after septum removal. Odds ratios (OR) with 95% confidence intervals (CI) were calculated for the outcome measures. A p-value < 0.05 was considered statistically significant. Subgroup analysis was performed according to the depth of the septum. Sources of heterogeneity were explored by meta-regression analysis according to specific features: assisted reproductive technology/spontaneous conception, study design and quality of papers included Results: data from 38 studies were extracted. (i) septum versus no septum: a lower PR and LBR were associated with septate uterus vs. controls (OR 0.45, 95% CI 0.27−0.76; p < 0.0001; and OR 0.21, 95% CI 0.12−0.39; p < 0.0001); a higher proportion of SA and PL was associated with septate uterus vs. controls (OR 4.29, 95% CI 2.90−6.36; p < 0.0001; OR 2.56, 95% CI 1.52−4.31; p = 0.0004). (ii) treated versus untreated septum: PR and PL were not different in removed vs. unremoved septum(OR 1.10, 95% CI 0.49−2.49; p = 0.82 and OR 0.81, 95% CI 0.35−1.86; p = 0.62); a lower proportion of SA was associated with removed vs. unremoved septum (OR 0.47, 95% CI 0.21−1.04; p = 0.001); (iii) before-after septum removal: the proportion of LBR was higher after the removal of septum (OR 49.58, 95% CI 29.93−82.13; p < 0.0001) and the proportion of SA and PL was lower after the removal of the septum (OR 0.02, 95% CI 0.02−0.04; p < 0.000 and OR 0.05, 95% CI 0.03−0.08; p < 0.0001) Conclusions: the results show the detrimental effect of the uterine septum on PR, LBR, SA and PL. Its treatment reduces the rate of SA.

Citing Articles

Hysteroscopic treatment of complete uterine septum, double cervix and longitudinal vaginal septum (U2bC2V1): the use of a Foley catheter balloon.

Triantafyllidou O, Panagodimou E, Syggelos N, Vlahos N Facts Views Vis Obgyn. 2024; 16(4):497-504.

PMID: 39718335 PMC: 11819783. DOI: 10.52054/FVVO.16.4.042.


Prevalence of Septate Uterus in a Large Population of Women of Reproductive Age: Comparison of ASRM 2016 and 2021, ESHRE/ESGE, and CUME Diagnostic Criteria: A Prospective Study.

Carriles I, Brotons I, Errasti T, Ruiz-Zambrana A, Ludwin A, Alcazar J Diagnostics (Basel). 2024; 14(18).

PMID: 39335698 PMC: 11431554. DOI: 10.3390/diagnostics14182019.


Is Hysteroscopic Metroplasty Advisable for U2bC2V1 Malformation?.

Goidescu I, Staicu A, Poienar A, Surcel M, Micu R, Boitor Borza D Diagnostics (Basel). 2024; 14(15).

PMID: 39125524 PMC: 11311479. DOI: 10.3390/diagnostics14151649.


Reproductive surgery remains an essential element of reproductive medicine.

Urman B, Ata B, Gomel V Facts Views Vis Obgyn. 2024; 16(2):145-162.

PMID: 38950529 PMC: 11366118. DOI: 10.52054/FVVO.16.2.022.


Effects of hysteroscopic septum incision versus expectant management on IVF outcomes in women with complete septate uterus: a retrospective study.

Zhang J, Kang J, Song X, Yang S, Yang Y, Qiao J BMC Womens Health. 2024; 24(1):202.

PMID: 38555467 PMC: 10981310. DOI: 10.1186/s12905-024-03022-1.


References
1.
Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

2.
Jayaprakasan K, Chan Y, Sur S, Deb S, Clewes J, Raine-Fenning N . Prevalence of uterine anomalies and their impact on early pregnancy in women conceiving after assisted reproduction treatment. Ultrasound Obstet Gynecol. 2011; 37(6):727-32. DOI: 10.1002/uog.8968. View

3.
Carrera M, Perez Millan F, Alcazar J, Alonso L, Caballero M, Carugno J . Effect of Hysteroscopic Metroplasty on Reproductive Outcomes in Women with Septate Uterus: Systematic Review and Meta-Analysis. J Minim Invasive Gynecol. 2021; 29(4):465-475. DOI: 10.1016/j.jmig.2021.10.001. View

4.
Paradisi R, Barzanti R, Natali F, Guerrini M, Battaglia C, Seracchioli R . Hysteroscopic metroplasty: reproductive outcome in relation to septum size. Arch Gynecol Obstet. 2013; 289(3):671-6. DOI: 10.1007/s00404-013-3003-9. View

5.
Tomazevic T, Ban-Frangez H, Virant-Klun I, Verdenik I, Pozlep B, Vrtacnik-Bokal E . Septate, subseptate and arcuate uterus decrease pregnancy and live birth rates in IVF/ICSI. Reprod Biomed Online. 2010; 21(5):700-5. DOI: 10.1016/j.rbmo.2010.06.028. View